GILD
GILEAD SCIENCES
Health Care·Biotechnology·UNITED STATES
$125.50
MCap $155.8B
as of 2026-06-09
Total
C1w
Fund
C1w
Quant
C1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
-0.56
Sentiment 82.8%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$125.50
Adaptive Mean
$126.91
-1.41 vs mean
Adaptive σ
1.25
MIDOS BB
$124.40 – $129.42
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+0.23
ROE
43.2%
Z +0.98
Rev Gr
4.4%
Z -0.26
EPS Gr
1700.0%
Z +4.42
OPM Gr
10.7%
Z -0.28
FCF Yld
6.2%
Z +0.43
EPS Surp
6.4%
Z -0.03
EPS 3mo Δ
-369.0%
Z -3.65
Fwd P/E
13.09
Z —
PEGY
0.01
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
-20.20
Q6M
0.58
Q12M
1.01
MA 30/100
0.951
Bearish (MA30 < MA100)
α (Jensen)
-0.8344
β (12M)
0.46
σ (12M)
0.263
Divergence — Fundamentals vs Momentum
Z Percentile
82%
Q Percentile
53%
Divergence
+28.2
Tier
RELOAD — WATCH
Fundamentals ahead of momentum.
Kirkpatrick RS & Persistence
RS
-5.6
RS Pctl
44%
RS Decile
D5
Persistence
1w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.